In terms of mechanism, downregulation of B-cell Lymphoma 2 (Bcl-2) expression and upregulation of FDX1 expression were detected in OC1 cells and cochlear explants exposed to CIS, which can be prevented by pretreatment with CUR/GOQDs. This evidence concerns the gene BCL2 and in situ carcinoma.